BIOGEN INC. Deferred Income Tax Expense (Benefit)
BIOGEN INC. (BIIB) reported Deferred Income Tax Expense (Benefit) of $23.60 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-04-29
- BIOGEN INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $23.60M.
- BIOGEN INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $166.90M.
- BIOGEN INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $253.80M.
- BIOGEN INC. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was -$31.30M.
- BIOGEN INC. deferred income tax expense (benefit) for fiscal 2025 was $361.60M.
- BIOGEN INC. deferred income tax expense (benefit) for fiscal 2024 was -$158.10M.
- BIOGEN INC. deferred income tax expense (benefit) for fiscal 2023 was -$305.80M.
- BIOGEN INC. deferred income tax expense (benefit) for fiscal 2022 was -$168.60M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $23.60M 10-Q · filed 2026-04-29 | $190.50M derived: sum of 2 quarters · filed 2026-04-29 | $444.30M derived: sum of 3 quarters · filed 2026-04-29 | $413.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $166.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $420.70M derived: sum of 2 quarters · filed 2026-02-06 | $389.40M derived: sum of 3 quarters · filed 2026-02-06 | $361.60M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $253.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $222.50M derived: sum of 2 quarters · filed 2025-10-30 | $194.70M 10-Q · filed 2025-10-30 | $136.30M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$31.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$59.10M 10-Q · filed 2025-07-31 | -$117.50M derived: sum of 3 quarters · filed 2026-04-29 | -$170.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$27.80M 10-Q · filed 2026-04-29 | -$86.20M derived: sum of 2 quarters · filed 2026-04-29 | -$138.80M derived: sum of 3 quarters · filed 2026-04-29 | -$225.80M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | -$58.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$111.00M derived: sum of 2 quarters · filed 2026-02-06 | -$198.00M derived: sum of 3 quarters · filed 2026-02-06 | -$158.10M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | -$52.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$139.60M derived: sum of 2 quarters · filed 2025-10-30 | -$99.70M 10-Q · filed 2025-10-30 | -$27.80M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | -$87.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$47.10M 10-Q · filed 2025-07-31 | $24.80M derived: sum of 3 quarters · filed 2026-02-06 | -$182.00M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $39.90M 10-Q · filed 2025-05-01 | $111.80M derived: sum of 2 quarters · filed 2026-02-06 | -$95.00M derived: sum of 3 quarters · filed 2026-02-06 | -$201.40M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $71.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$134.90M derived: sum of 2 quarters · filed 2026-02-06 | -$241.30M derived: sum of 3 quarters · filed 2026-02-06 | -$305.80M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | -$206.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$313.20M derived: sum of 2 quarters · filed 2024-10-30 | -$377.70M 10-Q · filed 2024-10-30 | -$406.50M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$106.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$170.90M 10-Q · filed 2024-08-01 | -$199.70M derived: sum of 3 quarters · filed 2025-02-12 | -$292.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$64.50M 10-Q · filed 2024-04-24 | -$93.30M derived: sum of 2 quarters · filed 2025-02-12 | -$185.60M derived: sum of 3 quarters · filed 2025-02-12 | -$234.10M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$28.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$121.10M derived: sum of 2 quarters · filed 2025-02-12 | -$169.60M derived: sum of 3 quarters · filed 2025-02-12 | -$168.60M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$92.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$140.80M derived: sum of 2 quarters · filed 2023-11-08 | -$139.80M 10-Q · filed 2023-11-08 | $183.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$48.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$47.50M 10-Q · filed 2023-07-25 | $275.80M derived: sum of 3 quarters · filed 2024-02-14 | $148.50M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $1.00M 10-Q · filed 2023-04-25 | $324.30M derived: sum of 2 quarters · filed 2024-02-14 | $197.00M derived: sum of 3 quarters · filed 2024-02-14 | -$410.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $323.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $196.00M derived: sum of 2 quarters · filed 2024-02-14 | -$411.80M derived: sum of 3 quarters · filed 2024-02-14 | -$426.80M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$127.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$735.10M derived: sum of 2 quarters · filed 2022-10-25 | -$750.10M 10-Q · filed 2022-10-25 | -$813.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$607.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$622.80M 10-Q · filed 2022-07-20 | -$685.70M derived: sum of 3 quarters · filed 2023-02-15 | -$654.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$15.00M 10-Q · filed 2022-05-03 | -$77.90M derived: sum of 2 quarters · filed 2023-02-15 | -$46.20M derived: sum of 3 quarters · filed 2023-02-15 | $97.10M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$62.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$31.20M derived: sum of 2 quarters · filed 2023-02-15 | $112.10M derived: sum of 3 quarters · filed 2023-02-15 | $149.00M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $31.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $175.00M derived: sum of 2 quarters · filed 2021-10-20 | $211.90M 10-Q · filed 2021-10-20 | $250.60M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $143.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $180.20M 10-Q · filed 2021-07-22 | $218.90M derived: sum of 3 quarters · filed 2022-02-03 | $175.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $36.90M 10-Q · filed 2021-04-22 | $75.60M derived: sum of 2 quarters · filed 2022-02-03 | $32.40M derived: sum of 3 quarters · filed 2022-02-03 | -$124.00M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $38.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$4.50M derived: sum of 2 quarters · filed 2022-02-03 | -$160.90M derived: sum of 3 quarters · filed 2022-02-03 | $67.10M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | -$43.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | -$199.60M derived: sum of 2 quarters · filed 2020-10-21 | $28.40M 10-Q · filed 2020-10-21 | $181.50M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$156.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | $71.60M 10-Q · filed 2020-07-22 | $224.70M derived: sum of 3 quarters · filed 2021-02-03 | $237.30M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $228.00M 10-Q · filed 2020-04-23 | $381.10M derived: sum of 2 quarters · filed 2021-02-03 | $393.70M derived: sum of 3 quarters · filed 2021-02-03 | $283.20M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $153.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $165.70M derived: sum of 2 quarters · filed 2021-02-03 | $55.20M derived: sum of 3 quarters · filed 2021-02-03 | $108.30M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $12.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$97.90M derived: sum of 2 quarters · filed 2019-10-22 | -$44.80M 10-Q · filed 2019-10-22 | $86.60M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$110.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$57.40M 10-Q · filed 2019-07-24 | $74.00M derived: sum of 3 quarters · filed 2020-02-06 | $54.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $53.10M 10-Q · filed 2019-04-24 | $184.50M derived: sum of 2 quarters · filed 2020-02-06 | $165.30M derived: sum of 3 quarters · filed 2020-02-06 | $68.70M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $131.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $112.20M derived: sum of 2 quarters · filed 2020-02-06 | $15.60M derived: sum of 3 quarters · filed 2020-02-06 | $91.70M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | -$19.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$115.80M derived: sum of 2 quarters · filed 2018-10-23 | -$39.70M 10-Q · filed 2018-10-23 | -$157.90M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | -$96.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$20.50M 10-Q · filed 2018-07-24 | -$138.70M derived: sum of 3 quarters · filed 2019-02-06 | -$165.30M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $76.10M 10-Q · filed 2018-04-24 | -$42.10M derived: sum of 2 quarters · filed 2019-02-06 | -$68.70M derived: sum of 3 quarters · filed 2019-02-06 | -$107.80M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$118.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$144.80M derived: sum of 2 quarters · filed 2019-02-06 | -$183.90M derived: sum of 3 quarters · filed 2019-02-06 | -$175.00M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | -$26.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | -$65.70M derived: sum of 2 quarters · filed 2017-10-24 | -$56.80M 10-Q · filed 2017-10-24 | -$16.60M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$39.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$30.20M 10-Q · filed 2017-07-25 | $10.00M derived: sum of 3 quarters · filed 2018-02-01 | -$85.20M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $8.90M 10-Q · filed 2017-04-25 | $49.10M derived: sum of 2 quarters · filed 2018-02-01 | -$46.10M derived: sum of 3 quarters · filed 2018-02-01 | -$153.40M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $40.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$55.00M derived: sum of 2 quarters · filed 2018-02-01 | -$162.30M derived: sum of 3 quarters · filed 2018-02-01 | -$145.60M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | -$95.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$202.50M derived: sum of 2 quarters · filed 2016-10-26 | -$185.80M 10-Q · filed 2016-10-26 | -$185.80M 10-Q · filed 2015-10-21 | -$264.73M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | -$107.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | -$90.60M 10-Q · filed 2016-07-21 | -$90.65M 10-Q · filed 2015-07-24 | -$169.53M derived: sum of 3 quarters · filed 2017-02-02 | -$252.29M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $16.70M 10-Q · filed 2016-04-21 | $16.74M 10-Q · filed 2015-04-24 | -$62.23M derived: sum of 2 quarters · filed 2017-02-02 | -$144.99M derived: sum of 3 quarters · filed 2017-02-02 | -$211.94M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$78.93M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$161.69M derived: sum of 2 quarters · filed 2017-02-02 | -$228.64M derived: sum of 3 quarters · filed 2017-02-02 | -$308.20M 10-K · filed 2017-02-02 | -$308.22M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$82.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | -$149.72M derived: sum of 2 quarters · filed 2015-10-21 | -$229.27M 10-Q · filed 2015-10-21 | -$308.19M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$66.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | -$146.51M 10-Q · filed 2015-07-24 | -$225.42M derived: sum of 3 quarters · filed 2016-02-03 | -$273.56M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | -$79.56M 10-Q · filed 2015-04-24 | -$158.47M derived: sum of 2 quarters · filed 2016-02-03 | -$206.61M derived: sum of 3 quarters · filed 2016-02-03 | -$258.13M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$78.91M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$127.05M derived: sum of 2 quarters · filed 2016-02-03 | -$178.57M derived: sum of 3 quarters · filed 2016-02-03 | -$245.10M 10-K · filed 2016-02-03 | -$245.08M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$48.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | -$99.66M derived: sum of 2 quarters · filed 2014-10-22 | -$166.19M 10-Q · filed 2014-10-22 | -$196.23M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | -$51.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-23 | -$118.05M 10-Q · filed 2014-07-23 | -$148.09M derived: sum of 3 quarters · filed 2015-02-04 | -$191.12M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$66.53M 10-Q · filed 2014-04-23 | -$96.57M derived: sum of 2 quarters · filed 2015-02-04 | -$139.59M derived: sum of 3 quarters · filed 2015-02-04 | -$179.55M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$30.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$73.07M derived: sum of 2 quarters · filed 2015-02-04 | -$113.02M derived: sum of 3 quarters · filed 2015-02-04 | -$116.90M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$43.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$82.98M derived: sum of 2 quarters · filed 2013-10-28 | -$86.86M 10-Q · filed 2013-10-28 | -$48.98M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | -$39.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$43.83M 10-Q · filed 2013-07-25 | -$5.95M derived: sum of 3 quarters · filed 2014-02-06 | $61.12M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | -$3.88M 10-Q · filed 2013-04-25 | $34.00M derived: sum of 2 quarters · filed 2014-02-06 | $101.07M derived: sum of 3 quarters · filed 2014-02-06 | $77.73M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $37.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $104.95M derived: sum of 2 quarters · filed 2014-02-06 | $81.60M derived: sum of 3 quarters · filed 2014-02-06 | $153.58M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $67.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-25 | $43.72M derived: sum of 2 quarters · filed 2012-10-25 | $115.70M 10-Q · filed 2012-10-25 | $95.53M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | -$23.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24 | $48.63M 10-Q · filed 2012-07-24 | $28.46M derived: sum of 3 quarters · filed 2013-02-05 | -$2.47M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $71.97M 10-Q · filed 2012-05-01 | $51.81M derived: sum of 2 quarters · filed 2013-02-05 | $20.88M derived: sum of 3 quarters · filed 2013-02-05 | -$17.48M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | -$20.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | -$51.09M derived: sum of 2 quarters · filed 2013-02-05 | -$89.45M derived: sum of 3 quarters · filed 2013-02-05 | -$81.41M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | -$30.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$69.29M derived: sum of 2 quarters · filed 2011-10-28 | -$61.24M 10-Q · filed 2011-10-28 | -$126.02M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | -$38.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | -$30.32M 10-Q · filed 2011-07-26 | -$95.09M derived: sum of 3 quarters · filed 2012-02-03 | -$124.90M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $8.04M 10-Q · filed 2011-04-21 | -$56.73M derived: sum of 2 quarters · filed 2012-02-03 | -$86.54M derived: sum of 3 quarters · filed 2012-02-03 | -$122.34M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | -$64.77M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | -$94.58M derived: sum of 2 quarters · filed 2012-02-03 | -$130.38M derived: sum of 3 quarters · filed 2012-02-03 | -$137.35M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | -$29.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$65.61M derived: sum of 2 quarters · filed 2010-10-26 | -$72.58M 10-Q · filed 2010-10-26 | -$154.54M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | -$35.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | -$42.77M 10-Q · filed 2010-07-20 | -$124.73M derived: sum of 3 quarters · filed 2011-02-04 | -$167.56M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | -$6.97M 10-Q · filed 2010-04-20 | -$88.93M derived: sum of 2 quarters · filed 2011-02-04 | -$131.76M derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | -$81.96M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | -$124.79M derived: sum of 2 quarters · filed 2011-02-04 | -$139.55M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | -$42.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | -$57.59M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | -$14.76M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | -$81.56M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |